详细内容
Trusted cancer diagnostics for all
Trusted. Proven. Deployed.
Every day, our field-proven, AI-powered diagnostic solutions help pathologists ensure better cancer care for patients around the world
Trusted
Created by pathologists
for pathologists
Proven
Delivering real-world
clinical impact
Deployed
The worldwide leader in
live clinical rollouts
Chosen
Platform of choice for the world’s leading physicians, health systems and diagnostic solution providers
Ibex Raises $55 Million in Series C Funding
The funding round is to Drive Global Adoption of AI for Cancer Diagnosis and was led by 83NORTH and included Sienna Venture Capital and existing investors Octopus Ventures, aMoon Fund, Planven Entrepreneur Ventures and Dell Technologies Capital.
The Ibex Difference
- AI-powered solutions detect cancer and more than a hundred other diagnostic features in multiple tissue types
- Clinically-proven accuracy, enhanced efficiency and improved user experience
- Developed from rich datasets extracted from over 10 million slides from multiple pathology institutes
- Multiple AI algorithms trained by teams of expert pathologists using deep learning technologies


“We are impressed with the study outcomes and performance of Ibex Breast, which were in near perfect concordance with the consensus diagnosis between pathologists. Our team demonstrated that Ibex’s AI technology goes beyond diagnosing cancer and provides accurate insights on the type of invasive carcinomas, the nuclear grading of in situ carcinomas and more. I’m confident that AI will provide benefit to cancer patients across the diagnostic workflow”

Anne Vincent-Salomon, MD
Institut Curie, Paris
“The use of AI in diagnosing prostatic cores made me extremely confident in making correct and reproducible tissue diagnosis by the entire pathology team. AI brings this technology into us, as a second pathologist, and it feels like I have an AI consultant sitting with me and helping in the diagnosis. We have been looking under microscopes for hundreds of years, and by adopting digital pathology and artificial intelligence, we are going into the 21st century, enhancing the quality of care to cancer patients”

Muhammad Aslam, MD
Betsi Cadwaladr University Health Board, Wales
“AI provides an additional prospective quality control, that we are looking at the right foci and identify the right areas of cancer. The ability of Ibex’s AI platform, not only to detect small foci of cancer that can be missed, but more interestingly and importantly higher-grade cancers that can be very small, make it a perfect companion for pathologists who are reviewing a lot of diagnostic material or may not have the expertise to analyze this material with that level of confidence.”

Mahul B. Amin, MD
The University of Tennessee Health Science Center
“I was the primary investigator in a study that validated the performance of Ibex’s Prostate solution. At the end of the study, the team was most impressed with how well the algorithm preformed, with an area under the curve close to near perfect, not only for the diagnosis cancer but also for other clinically relevant features such as Gleason grading, tumor sizing and detection of perineural invasion”

Liron Pantanowitz, MD
University of Michigan (University of Pittsburgh Medical Center at the time of the study)

Why Ibex
Experience >
Enhanced physician confidence and patient safety
Quality >
Accurate, timely, personalized cancer diagnosis for every patient
Outcomes >
Faster diagnosis, better user experience and lower pathology workloads
Trust >
Higher quality,
more targeted,
high-impact care
Efficiency >
Optimized workflows improve productivity across the cancer pathway
Customers & Partners
The role of AI in pathology and how it impacts cancer care
Prof. Stuart Schnitt from Brigham and Women’s Hospital talks about Ibex Breast and how its accuracy and broad detection capabilities transform pathologists’ work
Contact Us
*First Name
*Last Name
Phone
*Organization
Position
PathologistPhysician(other specialty)ResearcherDistributorExecutiveInvestorReporterOther
Message
I acknowledge that my data will be processed in accordance with IBEX Privacy Policy.
We will send you marketing and promotional messages by email, subject to applicable law and in accordance with our Privacy Policy. You can always opt-out from any such subscription.
Submit
TRUSTED
CANCER
DIAGNOSTICS
FOR ALL
Scroll to Top
Close GDPR Cookie Settings

- Privacy Overview
- Strictly Necessary Cookies
- 3rd Party Cookies
Powered by GDPR Cookie Compliance
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
Enable or Disable CookiesEnabledDisabled
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Enable or Disable CookiesEnabledDisabled
Enable AllSave Settings
